朗威股份：总经理高建强计划减持公司股份不超过250万股

Group 1 - The major shareholder, Mr. Gao Jianqiang, who holds 10.4 million shares (7.62% of total shares), plans to reduce his stake by up to 2.5 million shares (1.83% of total shares) within three months after the announcement date through centralized bidding or block trading [1] - Hai Li Biological's valuation has decreased by 50% over eight months despite a ninefold increase in the value of the acquired company, raising concerns about its first major client, which is a company that has not yet been established [1]